Biotech Late Stage Investors & VC Firms
652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.
HealthCare Ventures, LLC
CambridgeSeries A–Late Stage$1M – $20M
1 person
Level Eight Ventures
Ann ArborSeed–Late Stage
4 people
Biotechnology Value Fund
San FranciscoLate Stage
3 people
Octalfa
LyonPre-Seed–Late Stage$100K – $2.7M
Silverleaf Venture Partners, LLC
Fort MyersSeries A–Late Stage
3 people
Peppermint Holding
BerlinSeed–Late Stage
4 people
Heron Capital
IndianapolisSeries A–Late Stage$10M
3 people
Shanghai Creation Investment
ShanghaiLate Stage
Sherpa Healthcare Partners
Grand CaymanSeed–Late Stage
3 people
Trinity Innovation Bioventure Singapore
SingaporeSeed–Late Stage
3 people
Majuven
SingaporeSeed–Late Stage
4 people
South China Venture Capital
ShenzhenSeed–Late Stage
4 people
TTP Ventures
CambridgeSeed–Late Stage
Clarus Ventures
Menlo ParkPre-Seed–Late Stage
8 people
AgriBoom Ventures
Pre-Seed–Late Stage$10K – $4.4M
1 person
Fluke Venture Partners
KirklandSeed–Late Stage$1M – $4M
1 person
Realist Ventures
DarienSeed–Late Stage$25K – $500K
1 person
Aravis Ventures
ZurichSeed–Late Stage
4 people
Milano Investment Partners SGR
MilanSeed–Late Stage
10 people
Abbhi Capital
MiamiPre-Seed–Late Stage
Fulcrum Financial Partners
Raleigh-DurhamPre-Seed–Late Stage
3 people
Gurnet Point Capital
Pre-Seed–Late Stage
3 people
Invest Northern Ireland
BelfastSeed–Late Stage
ODYSSEE VENTURE
ParisSeed–Late Stage$1.1M – $11M
Related lists
Late Stage Investors & VC Firms (2974)Biotech Investors & VC Firms (2185)Biotech Seed Investors & VC Firms (1824)Late Stage Investors & VC Firms in North America (1695)Biotech Series A Investors & VC Firms (1668)Late Stage Investors & VC Firms in United States (1516)Biotech Investors & VC Firms in North America (1391)Biotech Investors & VC Firms in United States (1267)Late Stage Investors & VC Firms in Europe (965)Biotech Pre-Seed Investors & VC Firms (957)
Data sourced from public filings and firms' own websites — see our methodology.


























